Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Benjamin M. Parsons
ResearcherPublications, citations & collaboration network
Benjamin M. Parsons is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 253 works, 4,684 citations, an h-index of 27 and an i10-index of 41.
253
Works
4,684
Citations
27
h-index
41
i10-index
How has Benjamin M. Parsons's publication output changed over time?
ScholarIQpublication output · 2011–2024
Output declined50% over the shown period — from 2 works in 2011 to 1 in 2024.
2
2
2
1
1
1
1
1
20112015201620172018201920202024
What are the most-cited papers on Benjamin M. Parsons?
ScholarIQmost cited works
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu, Richard S. Finn, Julien Edeline, Stéphane Cattan, Sadahisa Ogasawara, Daniel H. Palmer, Chris Verslype, Vittorina Zagonel, Lætitia Fartoux, Arndt Vogel, Debashis Sarker, Gontran Verset, Stephen L. Chan, Jennifer J. Knox, Bruno Daniele, Andrea L. Webber, Scot Ebbinghaus, Junshui Ma, Abby B. Siegel, Ann‐Lii Cheng, Masatoshi Kudo, Angela Alistar, Jamil Asselah, Jean‐Frédéric Blanc, Ivan Borbath, Timothy Lewis Cannon, Ki Y. Chung, Allen Lee Cohn, David Cosgrove, Nevena Damjanov, Mukul Gupta, Yoshivasu Karino, Mark Karwal, Andreas Kaubisch, Robin Kate Kelley, Jena-Luc Van Laethem, Timothy Larson, James Lee, Daneng Li, Atisha Manhas, Gulam A. Manji, Kazushi Numata, Benjamin M. Parsons, Andrew Scott Paulson, Carmine Pinto, Robert A. Ramirez, Suresh Ratnam, Magnus Rizell, Olivier Rosmorduc, Yvonne H. Sada, Yutaka Sasaki, Per Stål, Simone I. Strasser, Joerg Trojan, Gina M. Vaccaro, Hans Van Vlierberghe, Alan Weiss, Karl-Heinz Weiss, Tatsuya Yamashita
The Lancet Oncology. 20182,547 Citations
Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial
Shaji Kumar, Susanna Jacobus, Adam D. Cohen, Matthias Weiss, Natalie S. Callander, Avina K. Singh, Terri L. Parker, Alexander Menter, Xuezhong Yang, Benjamin M. Parsons, Pankaj Kumar, Prashant Kapoor, Aaron S. Rosenberg, Jeffrey A. Zonder, Edward A. Faber, Sagar Lonial, Kenneth C. Anderson, Paul G. Richardson, Robert Z. Orlowski, Lynne I. Wagner, S. Vincent Rajkumar
The Lancet Oncology. 2020259 CitationsOPEN ACCESS
A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era
Andrew M. Evens, Irene Helenowski, Erika Ramsdale, Chadi Nabhan, Reem Karmali, Britt Hanson, Benjamin M. Parsons, Scott E. Smith, Annette K. Larsen, June M. McKoy, Borko Jovanovic, Stephanie Gregory, Leo I. Gordon, Sonali M. Smith
Blood. 2011159 CitationsOPEN ACCESS
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy
Jennifer L. Crombie, Tara Graff, Lorenzo Falchi, Yasmin Karimi, Rajat Bannerji, Loretta J. Nastoupil, Catherine Thiéblemont, Rénata Ursu, Nancy L. Bartlett, Victoria Nachar, J. Weiss, Jane Osterson, Krish Patel, Joshua Brody, Jeremy S. Abramson, Matthew A. Lunning, Nirav N. Shah, Ayed O. Ayed, Manali Kamdar, Benjamin M. Parsons, Paolo F. Caimi, Ian W. Flinn, Alex F. Herrera, Jeffrey P. Sharman, Marshall McKenna, Philippe Armand, Brad S. Kahl, Sonali M. Smith, Andrew D. Zelenetz, Lihua E. Budde, Martin Hutchings, Tycel Phillips, Michael Dickinson
Blood. 2024136 CitationsOPEN ACCESS
Prognostic impact of concurrent <i>MYC</i> and <i>BCL6</i> rearrangements and expression in <i>de novo</i> diffuse large B-cell lymphoma
Qing Ye, Zijun Y. Xu‐Monette, Alexandar Tzankov, Lijuan Deng, Xiaoxiao Wang, Ganiraju C. Manyam, Carlo Visco, Santiago Montes‐Moreno, Li Zhang, Karen Dybkær, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L. Richards, Eric D. Hsi, William W.L. Choi, J. Han van Krieken, Jooryung Huh, Maurilio Ponzoni, Andrés J.M. Ferreri, Benjamin M. Parsons, Michael Møller, Miguel Á. Piris, Jane N. Winter, L. Jeffrey Medeiros, Shimin Hu, Ken H. Young
Oncotarget. 2015115 CitationsOPEN ACCESS
Related on ScholarIQ
Gundersen Health System
Institution
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Paper
Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial
Paper
A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era
Paper
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy
Paper
Prognostic impact of concurrent <i>MYC</i> and <i>BCL6</i> rearrangements and expression in <i>de novo</i> diffuse large B-cell lymphoma
Paper